DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY
1 total filings · 0 classes · Active since Jan 2025
DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 3/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed November 10, 2026
Protect or track "DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 98935691 | DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY | Jan 03, 2025 | Registered | 005 Pharmaceuticals 042 Science & Technology | Replimune Limited |
Weekly visibility reports showing how ChatGPT mentions DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY trademark portfolio
What trademarks does DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY hold?
DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals), Class 42 (Science & Technology). The most recent filings are registered to Replimune Limited.
How many trademarks does DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY. The brand has been actively filing since January 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY file most often?
DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY trademark?
The most recent filings under the DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY mark are registered to Replimune Limited. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY expanding into new categories?
The current WikiTrademarks Expansion Score for DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY is 3 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY trademark filings?
Click the Watch Brand button at the top of this page to add DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY and help the next person researching it.